Quantcast

Latest Eastern Cooperative Oncology Group Stories

2014-05-06 23:06:23

Expands Relationship of Innovation and Efficiencies (PRWEB) May 06, 2014 Florida Cancer Specialists & Research Institute (FCS), one of the largest

2014-04-10 23:27:08

In CHAMPS Oncology's most recent blog post, Celebrating National Cancer Registrars Week, Toni Hare shares her thoughts on the topic. Cleveland, OH (PRWEB)

2014-03-20 23:22:02

Entinostat is being investigated in patients with advanced hormone receptor-positive breast cancer by the ECOG-ACRIN Cancer Research Group in its latest trial, E2112. Philadelphia,

2014-03-03 23:22:56

Allegheny Health Network Cancer Institute has earned QOPI® (Quality Oncology Practice Initiative) Certification for its commitment to achieving excellence and ongoing quality improvement

2014-02-05 12:28:35

New Members Contribute Expertise and Vision to LUNGevity's Research Program WASHINGTON, Feb.

2014-02-03 23:02:17

Ibrutinib, a small molecule inhibitor of Bruton’s tyrosine kinase, will be investigated in combination with rituximab by the ECOG-ACRIN Cancer Research Group in its latest clinical trial, E1912.

2014-02-03 08:27:30

WALTHAM, Mass., Feb. 3, 2014 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., today announced the appointment of distinguished breast cancer specialist, George W.

2014-01-09 23:01:40

Blinatumomab, the first BiTE® antibody to be developed for the treatment of cancer, is being investigated by the ECOG-ACRIN Cancer Research Group in its latest trial, E1910. Philadelphia,

2013-12-13 23:01:59

An analysis by ECOG-ACRIN researchers shows that TILs are a prognostic factor in women with triple negative breast cancer. San Antonio, TX (PRWEB) December 13,


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related